Moreover, the miR-494-3p-inhibitor effectively inhibited the sEV-induced migration of cancer cells and VEGF-induced proliferation and migration of endothelial cells, suggesting that miR-494-3p in sEVs could function as a tumor promoter in an autocrine and paracrine manner in the TME. The gene discussed is VEGFA; the disease is neoplasm.